| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000nam a22000007i 4500 |
| 001 |
in00004726621 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
230610s2023 gw o 000 0 eng d |
| 005 |
20260214212147.9 |
| 020 |
|
|
|a 9783527841165
|q electronic book
|
| 020 |
|
|
|a 3527841164
|q electronic book
|
| 020 |
|
|
|a 9783527841189
|q electronic book
|
| 020 |
|
|
|a 3527841180
|q electronic book
|
| 020 |
|
|
|z 9783527351756
|q hardcover
|
| 020 |
|
|
|z 3527351752
|q hardcover
|
| 035 |
|
|
|a wil6007436
|
| 035 |
|
|
|a (NhCcYBP)wil6007436
|
| 040 |
|
|
|a NhCcYBP
|b eng
|e rda
|c NhCcYBP
|
| 050 |
|
4 |
|a RC280.B8
|b D78 2023
|
| 082 |
0 |
4 |
|a 616.99/449
|2 23/eng/20230628
|
| 245 |
0 |
0 |
|a Drug and therapy development for triple negative breast cancer /
|c edited by Pravin Kendrekar, Vinayak Adimule, Tara Hurst.
|
| 264 |
|
1 |
|a Weinheim, Germany :
|b Wiley-VCH,
|c [2023]
|
| 300 |
|
|
|a 1 online resource (323 p.)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Description based upon print version of record.
|
| 505 |
0 |
|
|a Intro -- Title Page -- Contents -- Preface -- Part I History of Breast Cancer -- 1 Early-Stage Diagnosis of Breast Cancer: Amelioration in Approaches -- 1.1 Introduction -- 1.2 Imaging Techniques -- 1.2.1 Mammography (MG) -- 1.2.2 Ultrasonography (US) -- 1.2.3 Magnetic Resonance Imaging (MRI) -- 1.3 Microwave Breast Imaging Methods -- 1.3.1 Microwave Tomography -- 1.3.2 Radio-Based Microwave Imaging -- 1.4 Biomarkers and Biosensors for Breast Cancer Detection -- 1.4.1 Biomarkers -- 1.4.2 Biosensors -- 1.5 Conclusion -- Acknowledgment -- Conflict of Interest -- Authors Contribution
|
| 504 |
|
|
|a References -- 2 DNA Replication Stress and Genome Instability in Breast Cancer -- 2.1 Introduction -- 2.2 Causes of Replication Stress and Genomic Instability -- 2.2.1 Replication Dysfunction -- 2.2.2 Transcription-Induced Stress -- 2.2.3 Genomic Aberrations and Instability -- 2.3 Molecular Mechanism of Genomic Instability -- 2.3.1 Problems Faced During DNA Damage Repair -- 2.3.2 Transcriptional Stress -- 2.3.3 CIN: Result of Defective Mitosis -- 2.4 Aftermath of Replication Stress on Cell and Its Fate -- 2.4.1 Conservation of Stalled Replication Forks
|
| 505 |
8 |
|
|a 2.4.2 Chromosome Segregation Defect Check by HR Repair -- 2.4.3 Aging, Cell Death, and Senescence -- 2.5 Therapeutic Approach -- 2.6 Conclusion -- Abbreviations -- References -- 3 Recent Advancement of Nanotherapeutics to Treat Breast Cancer -- 3.1 Introduction -- 3.2 Pathophysiology of Breast Cancer -- 3.3 Classification of Breast Cancer -- 3.4 Techniques for Breast Cancer Detection -- 3.5 Current Breast Cancer Therapies -- 3.6 Nanotherapeutics for Breast Cancer Treatment and Metastasis -- 3.6.1 Nanodiamonds (NDs) -- 3.6.2 Intrinsic Toxicity Reduction -- 3.6.3 Diminishing Chemoresistance (CR)
|
| 505 |
8 |
|
|a 3.6.4 Delivery of Combination Therapeutics Through NDs -- 3.7 Polymer-Based Nanoparticles (PBNPs) -- 3.8 Inorganic Nanoparticles (IONPs) -- 3.9 Hydrogels (HGLs) and Microbubbles (MBs) -- 3.10 Recent Patents of Nanotherapeutics for Breast Cancer Treatment -- 3.11 Clinical Trials of Nanotherapeutics for Breast Cancer -- 3.12 Conclusion and Future Perspectives -- References -- 4 HER Receptor in Breast Cancer -- 4.1 Introduction -- 4.2 Role of HER Receptors in the Human Body -- 4.3 HER2 Receptor in Breast Cancer Progression -- 4.4 Conclusion -- Conflict of Interest -- References
|
| 505 |
8 |
|
|a 5 Human Endogenous Retroviruses in Triple-Negative Breast Cancer -- 5.1 Introduction -- 5.2 HERVs in Breast Cancer and TNBC -- 5.3 TROJAN lncRNA and TNBC -- 5.4 HERVs and Breast Cancer Treatments -- 5.5 Conclusion -- 5.6 Search Strategy -- References -- Part II Novel Drug Discovery and Development -- 6 Development in Drug Repurposing for the Treatment of Acute Leukemia Complicating Metastatic Breast Cancer -- 6.1 Introduction -- 6.1.1 Acute Leukemia's -- 6.1.2 Mitochondrial cAMP-PKA Signaling -- 6.1.3 Nuclear Compartment -- 6.1.4 Cytosolic Compartment and Plasma Membrane -- 6.2 Conclusion
|
| 500 |
|
|
|a Conflict of Interest
|
| 588 |
|
|
|a Description based on online resource; title from digital title page (viewed on June 28, 2023).
|
| 650 |
|
0 |
|a Breast
|x Cancer
|x Treatment.
|
| 655 |
|
0 |
|a Electronic books.
|
| 700 |
1 |
|
|a Kendrekar, Pravin,
|e editor.
|
| 700 |
1 |
|
|a Adimule, Vinayak,
|e editor.
|
| 700 |
1 |
|
|a Hurst, Tara,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|a Kendrekar, Pravin
|t Drug and Therapy Development for Triple Negative Breast Cancer
|d Newark : John Wiley & Sons, Incorporated,c2023
|z 9783527351756
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://onlinelibrary.wiley.com/book/10.1002/9783527841165
|z Connect to the full text of this electronic book
|t 0
|
| 955 |
|
|
|a Wiley EBA record
|
| 975 |
|
|
|p Wiley UBCM Full Collection 2026
|
| 999 |
f |
f |
|s 24f922e7-772f-406e-8cbd-445ded0ddd8e
|i 98843f2b-3f84-4168-ba24-2d0d2129775b
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|s evans_pda
|d Available Online
|t 0
|e RC280.B8 D78 2023
|h Library of Congress classification
|
| 998 |
f |
f |
|a RC280.B8 D78 2023
|t 0
|l Available Online
|